Anakinra treatment for refractory cerebral autoinflammatory responses
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51500
Abstract: Refractory cerebral autoinflammatory–autoimmune diseases are often associated with dysregulated innate immunity and are targeted by anakinra, an interleukin‐1 receptor antagonist. We analyzed the therapeutic effect of anakinra in refractory cerebral autoinflammatory response (CAIR) at a… read more here.
Keywords: autoinflammatory responses; anakinra treatment; refractory cerebral; cerebral autoinflammatory ... See more keywords
Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID‐19 patients: A meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24434
Abstract: Anakinra is being empirically considered for the treatment of COVID‐19 patients. The aim is to assess the efficacy of anakinra treatment on inflammatory marker reduction, including c‐reactive protein (CRP) concentrations, serum ferritin, and serum d‐dimer… read more here.
Keywords: covid patients; anakinra treatment; efficacy; inflammatory ... See more keywords
AB0785 TREATING IDIOPATHIC RECURRENT PERICARDITIS WITH INTERLEUKIN-1 INHIBITORS - A SINGLE CENTER EXPERIENCE
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.4037
Abstract: Pericarditis is a common disease with significant morbidity (1). Idiopathic pericarditis, where an underlying cause cannot be identified, makes up for 80% of cases in the Western World (1). Up to 30% of these patients… read more here.
Keywords: anakinra treatment; idiopathic recurrent; treatment; recurrent pericarditis ... See more keywords
Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2022.942455
Abstract: Objective The study aimed to report the efficacy and safety of anakinra treatment in patients with the refractory multisystemic inflammatory syndrome in children (MIS-C). Methods This is a cross-sectional retrospective study consisting of pediatric patients… read more here.
Keywords: anakinra treatment; inflammatory syndrome; syndrome children; children mis ... See more keywords